about the author

Josh Sullivan

josh@endpointsnews.com

author articles

As Omi­cron-spe­cif­ic boost­ers are in the news, BioN­Tech to ex­pand Ger­man site work­force by 200 em­ploy­ees

4 years ago
Manufacturing

Well-con­nect­ed, Gilead-backed biotech gets an­oth­er stack of cash to pur­sue CAR-Ts for au­toim­mune dis­ease

4 years ago
Financing
Cell/Gene Tx

FDA slams door to piv­otal tri­al for bub­ble boy dis­ease gene ther­a­py as Mus­tang Bio runs in­to an­oth­er hold

4 years ago
Cell/Gene Tx

Backed by Bay­er's Leaps, Boston-based Celli­no lands $80M for cell ther­a­py-in-box

4 years ago
Financing
Startups

Eli Cas­din co-leads $250M in­fu­sion in­to mi­croflu­idics play­er that land­ed NIH fund­ing for Covid-19 test­ing

4 years ago
Financing
Deals

Covid-19 roundup: FDA green­lights Gilead­'s Vek­lury for out­pa­tient use; WHO head warns world is primed for more ...

4 years ago
Coronavirus

FDA's do­mes­tic in­spec­tion hold will con­tin­ue un­til Feb­ru­ary

4 years ago
Manufacturing

Yingli Phar­ma brings small mol­e­cule re­search to the US in new pact with MD An­der­son; UCB's pso­ri­at­ic arthri­tis drug ...

4 years ago
News Briefing

Flori­da man con­vict­ed of fal­si­fy­ing clin­i­cal tri­al re­sults sen­tenced to over 2 years in prison

4 years ago
Outsourcing
FDA+

A Sen­ate bill wants to even an 'un­lev­el play­ing field' for do­mes­tic, for­eign in­spec­tion drop-ins amid back­log

4 years ago
Manufacturing

Re­call re­port: Miss­ing la­bel, mi­cro­bial con­t­a­m­i­na­tion leads to re­call of two batch­es of two drugs

4 years ago
Manufacturing

Man­u­fac­tur­ing woes con­tin­ue for Au­robindo af­ter FDA's warn­ing let­ter

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: New pro­duc­tion site opens in Africa; Sen­a­tor calls for test prices to be slashed

4 years ago
Manufacturing

Johns Hop­kins and lo­cal biotech team up for new man­u­fac­tur­ing site; New oral drug plat­form to help ac­cel­er­ate R&D ...

4 years ago
Manufacturing

Fol­low­ing CRL, Re­vance says it's clear on in­struc­tions for re­sub­mit­ting BLA

4 years ago
Manufacturing

A George Church spin­out fight­ing the vi­ral vec­tor bot­tle­neck in cell and gene ther­a­py lands $55M

4 years ago
Financing
Manufacturing

UK up­start rais­es $100M in bid to dig­i­tize and stan­dard­ize cell and gene ther­a­py man­u­fac­tur­ing

4 years ago
Cell/Gene Tx
Manufacturing

Covid-19 roundup: Pfiz­er ex­pands in­to France; Omi­cron-spe­cif­ic ver­sion of Mod­er­na's boost­er com­ing soon 

4 years ago
Coronavirus

Fol­low­ing a tu­mul­tuous year, Emer­gen­t's founder will re­tire in April

4 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: NY biotech primed to be­come Im­mu­ni­ty­Bio's drug sub­stance gold­mine; Illi­nois set to ...

4 years ago
R&D

FDA con­cerns at con­trac­tor Catal­ent site spurred on short­ages of No­vo Nordisk's semaglu­tide — re­port

4 years ago
Manufacturing

Largest Catal­ent site will ex­pand cold chain of­fer­ings; First phase com­plet­ed for Avid's CA up­grade 

4 years ago
Manufacturing

Pfiz­er says it's ready to ramp up Paxlovid pro­duc­tion. Ex­perts say it's not that easy

4 years ago
Manufacturing

Q&A: NECI's newest CEO talks pas­sion, dis­rup­tion and not fear­ing change

4 years ago
People
Manufacturing
First page Previous page 567891011 Next page Last page
A service from the Financial Times